29 results
424B5
CELU
Celularity Inc - Ordinary Shares
28 Jul 23
Prospectus supplement for primary offering
4:24pm
this necessary capital or address our liquidity needs may force us to delay, limit or terminate our operations, make further reductions in our workforce … announced reprioritization of efforts, which resulted in a reduction of approximately one-third of our workforce as of March 2023.
Our Celularity
424B3
CELU
Celularity Inc - Ordinary Shares
2 Jun 23
Prospectus supplement
5:00pm
in our workforce, discontinue our commercialization efforts for our biomaterials products as well as other clinical trial programs, liquidate all … reprioritization of efforts which resulted in a reduction of approximately one-third of our workforce as of March 2023.
Our Celularity IMPACT platform
424B5
y9n3csuvbzmh
6 Apr 23
Prospectus supplement for primary offering
9:03pm
424B3
bcqrg1g
1 Jun 22
Prospectus supplement
4:06pm
424B3
zcbygv
3 May 22
Prospectus supplement
4:06pm
POS AM
zitrb84vz7s7yjldq
1 Apr 22
Prospectus update (post-effective amendment)
9:15pm
424B3
knzq7y
12 Aug 21
Prospectus supplement
4:21pm
424B3
833gz oio48
25 Jun 21
Prospectus supplement
12:48pm